Literature DB >> 34099716

Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice.

Béatrice S-Y Choi1,2, Noëmie Daniel1,2, Vanessa P Houde1,2, Adia Ouellette1,2, Bruno Marcotte1,2, Thibault V Varin2, Cécile Vors2, Perrine Feutry2, Olga Ilkayeva3, Marcus Ståhlman4, Philippe St-Pierre1,2, Fredrik Bäckhed4,5, Angelo Tremblay1,2, Phillip J White3,6, André Marette7,8.   

Abstract

Animal models of human diseases are classically fed purified diets that contain casein as the unique protein source. We show that provision of a mixed protein source mirroring that found in the western diet exacerbates diet-induced obesity and insulin resistance by potentiating hepatic mTORC1/S6K1 signaling as compared to casein alone. These effects involve alterations in gut microbiota as shown by fecal microbiota transplantation studies. The detrimental impact of the mixed protein source is also linked with early changes in microbial production of branched-chain fatty acids (BCFA) and elevated plasma and hepatic acylcarnitines, indicative of aberrant mitochondrial fatty acid oxidation. We further show that the BCFA, isobutyric and isovaleric acid, increase glucose production and activate mTORC1/S6K1 in hepatocytes. Our findings demonstrate that alteration of dietary protein source exerts a rapid and robust impact on gut microbiota and BCFA with significant consequences for the development of obesity and insulin resistance.

Entities:  

Year:  2021        PMID: 34099716     DOI: 10.1038/s41467-021-23782-w

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  48 in total

1.  90th Anniversary Commentary: The mTORC1 Complex-A Central Player in the Control and Regulation of Amino Acid Sufficiency.

Authors:  Daniel Tomé
Journal:  J Nutr       Date:  2018-10-01       Impact factor: 4.798

2.  Low-Molecular-Weight Peptides from Salmon Protein Prevent Obesity-Linked Glucose Intolerance, Inflammation, and Dyslipidemia in LDLR-/-/ApoB100/100 Mice.

Authors:  Geneviève Chevrier; Patricia L Mitchell; Laurie-Eve Rioux; Fida Hasan; Tianyi Jin; Cyril Roland Roblet; Alain Doyen; Geneviève Pilon; Philippe St-Pierre; Charles Lavigne; Laurent Bazinet; Hélène Jacques; Tom Gill; Roger S McLeod; André Marette
Journal:  J Nutr       Date:  2015-05-20       Impact factor: 4.798

3.  Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability.

Authors:  Frédéric Tremblay; Michael Krebs; Luce Dombrowski; Attila Brehm; Elisabeth Bernroider; Erich Roth; Peter Nowotny; Werner Waldhäusl; André Marette; Michael Roden
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 4.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

5.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

6.  Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.

Authors:  Frédéric Tremblay; Sophie Brûlé; Sung Hee Um; Yu Li; Kohei Masuda; Michael Roden; Xiao Jian Sun; Michael Krebs; Roberto D Polakiewicz; George Thomas; André Marette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

7.  The protein source determines the potential of high protein diets to attenuate obesity development in C57BL/6J mice.

Authors:  Ulrike Liisberg; Lene Secher Myrmel; Even Fjære; Alexander K Rønnevik; Susanne Bjelland; Kristin Røen Fauske; Jacob Bak Holm; Astrid Linde Basse; Jacob B Hansen; Bjørn Liaset; Karsten Kristiansen; Lise Madsen
Journal:  Adipocyte       Date:  2016-03-17       Impact factor: 4.534

8.  Intake of hydrolyzed casein is associated with reduced body fat accretion and enhanced phase II metabolism in obesity prone C57BL/6J mice.

Authors:  Morten Rahr Clausen; Xumin Zhang; Christian C Yde; Ditte B Ditlev; Haldis H Lillefosse; Lise Madsen; Karsten Kristiansen; Bjørn Liaset; Hanne C Bertram
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

9.  Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial.

Authors:  Alison M Hill; Kristina A Harris Jackson; Michael A Roussell; Sheila G West; Penny M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  2015-09-09       Impact factor: 7.045

10.  Beef, Casein, and Soy Proteins Differentially Affect Lipid Metabolism, Triglycerides Accumulation and Gut Microbiota of High-Fat Diet-Fed C57BL/6J Mice.

Authors:  Muhammad Umair Ijaz; Muhammad Ijaz Ahmed; Xiaoyou Zou; Muzahir Hussain; Min Zhang; Fan Zhao; Xinglian Xu; Guanghong Zhou; Chunbao Li
Journal:  Front Microbiol       Date:  2018-09-24       Impact factor: 5.640

View more
  8 in total

1.  Mitochondrial Function and Microbial Metabolites as Central Regulators of Intestinal Immune Responses and Cancer.

Authors:  Saskia Weber-Stiehl; Lea Järke; Juan Camilo Castrillón-Betancur; Felix Gilbert; Felix Sommer
Journal:  Front Microbiol       Date:  2022-06-29       Impact factor: 6.064

Review 2.  (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders.

Authors:  Jyoti Sihag; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2022-01-14       Impact factor: 3.876

3.  Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice.

Authors:  Noëmie Daniel; Renato Tadeu Nachbar; Thi Thu Trang Tran; Adia Ouellette; Thibault Vincent Varin; Aurélie Cotillard; Laurent Quinquis; Andréanne Gagné; Philippe St-Pierre; Jocelyn Trottier; Bruno Marcotte; Marion Poirel; Mathilde Saccareau; Marie-Julie Dubois; Philippe Joubert; Olivier Barbier; Hana Koutnikova; André Marette
Journal:  Nat Commun       Date:  2022-03-15       Impact factor: 17.694

Review 4.  Rewiring host-microbe interactions and barrier function during gastrointestinal inflammation.

Authors:  Sune K Jensen; Simone I Pærregaard; Emma P Brandum; Astrid S Jørgensen; Gertrud M Hjortø; Benjamin A H Jensen
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-03-11

5.  The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.

Authors:  Jean Debédat; Tiphaine Le Roy; Lise Voland; Eugeni Belda; Rohia Alili; Solia Adriouch; Pierre Bel Lassen; Kazuyuki Kasahara; Evan Hutchison; Laurent Genser; Licia Torres; Camille Gamblin; Christine Rouault; Jean-Daniel Zucker; Nathalie Kapel; Christine Poitou; Geneviève Marcelin; Federico E Rey; Judith Aron-Wisnewsky; Karine Clément
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 6.  Dietary regulation in health and disease.

Authors:  Qi Wu; Zhi-Jie Gao; Xin Yu; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-23

7.  The Metabolic Role and Therapeutic Potential of the Microbiome.

Authors:  Louise E Olofsson; Fredrik Bäckhed
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

Review 8.  Diet Impact on Obesity beyond Calories and Trefoil Factor Family 2 (TFF2) as an Illustration: Metabolic Implications and Potential Applications.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Biomolecules       Date:  2021-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.